These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18045028)

  • 1. [Are IL2 receptor antagonist useful in high risk acute tubular necrosis kidney recipients?].
    Fernández A; Royuela A; Quintás A; Zamora J
    Nefrologia; 2007; 27(5):534-6. PubMed ID: 18045028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallopamil reduces the post-transplantation acute tubular necrosis in kidneys from aged donors.
    Lustig S; Shmueli D; Boner G; Bar-Nathan N; Nakache R; Yussim A; Shahrabani E; Shapira Z
    Isr J Med Sci; 1996 Dec; 32(12):1249-51. PubMed ID: 9007165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis.
    Bronzatto EJ; da Silva Quadros KR; Santos RL; Alves-Filho G; Mazzali M
    Transplant Proc; 2009 Apr; 41(3):849-51. PubMed ID: 19376369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of pretransplant soluble glycoprotein 130 (sgp130) plasma levels and posttransplant acute tubular necrosis in renal transplant recipients.
    Sadeghi M; Daniel V; Lahdou I; Döhler B; Naujokat C; Renner FC; Weimer R; Fonouni H; Mehrabi A; Schmidt J; Schenk M; Zeier M; Opelz G
    Transplantation; 2009 Jul; 88(2):266-71. PubMed ID: 19623024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of kidney transplantation from older living donors to older recipients.
    Gill J; Bunnapradist S; Danovitch GM; Gjertson D; Gill JS; Cecka M
    Am J Kidney Dis; 2008 Sep; 52(3):541-52. PubMed ID: 18653267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of deceased donor age and old-for-old allocation on kidney transplant outcome.
    Moers C; Kornmann NS; Leuvenink HG; Ploeg RJ
    Transplantation; 2009 Aug; 88(4):542-52. PubMed ID: 19696638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
    Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
    Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
    Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for graft dysfunction in the late period of renal transplantation.
    Mattoso R; Khouri N; de Jesus L; Marcílio de Souza CA
    Transplant Proc; 2009 Jun; 41(5):1594-8. PubMed ID: 19545687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for delayed graft function defined as need for dialysis or failure of creatinine to fall by 10% in the first 24 hours after transplant.
    Stratopoulos C; Roberts IS; Brockmann J; Zilvetti M; Muthusamy A; Vaidya A; Sinha S; Friend PJ
    Exp Clin Transplant; 2008 Mar; 6(1):37-41. PubMed ID: 18405243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term kidney regraft survival from deceased donors: risk factors and outcomes in a single center.
    Arnol M; Prather JC; Mittalhenkle A; Barry JM; Norman DJ
    Transplantation; 2008 Oct; 86(8):1084-9. PubMed ID: 18946346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant inflammation: a risk factor for delayed graft function?
    Lauzurica R; Pastor MC; Bayés B; Hernandez JM; Bonet J; Doladé M; Navarro M; Romero R
    J Nephrol; 2008; 21(2):221-8. PubMed ID: 18446717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors among donor characteristics which affect graft outcome in paired kidney transplantation.
    Tian YF; Liao CH; Chen MJ
    Transplant Proc; 2008 Sep; 40(7):2281-4. PubMed ID: 18790212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States.
    Schold JD; Rehman S; Kayle LK; Magliocca J; Srinivas TR; Meier-Kriesche HU
    Transpl Int; 2009 Jun; 22(6):626-34. PubMed ID: 19207187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
    Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005.
    Collins MG; Chang SH; Russ GR; McDonald SP
    Transplantation; 2009 Apr; 87(8):1201-9. PubMed ID: 19384167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a 6-month follow-up.
    Wagner K; Neumayer HH
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1353-7. PubMed ID: 3547865
    [No Abstract]   [Full Text] [Related]  

  • 20. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation.
    Oto T; Excell L; Griffiths AP; Levvey BJ; Snell GI
    J Heart Lung Transplant; 2008 Jan; 27(1):78-85. PubMed ID: 18187091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.